Vontobel Holding’s Takeda Pharmaceutical TAK Stock Holding History

Vontobel Holding’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$282K	Hold	17,619	–	–	﹤0.01%	1252
2026 Q1	$326K	Hold	17,619	–	–	﹤0.01%	979
2025 Q4	$275K	Hold	17,619	–	–	﹤0.01%	1199
2025 Q3	$258K	Hold	17,619	–	–	﹤0.01%	1150
2025 Q2	$272K	Hold	17,619	–	–	﹤0.01%	1078
2025 Q1	$262K	Buy	+17,619	New	+$247K	﹤0.01%	933

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vontobel Holding's TAK Position: Q2 2026 in Review

Vontobel Holding held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 17,619 shares worth $282K. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

Vontobel Holding first reported a position in TAK in Q1 2025 and has held it in 6 quarters since. The position peaked at $326K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Vontobel Holding held 17,619 shares of Takeda Pharmaceutical worth $282K as of Q2 2026.
Vontobel Holding left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Vontobel Holding's portfolio in Q2 2026, its #1252 holding.
Vontobel Holding first reported a position in Takeda Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
Vontobel Holding's Takeda Pharmaceutical position peaked at $326K in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.